ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 244 filers reported holding ALKERMES PLC in Q1 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 8,964,640 | $234,246,043 | 27.88% |
Krensavage Asset Management, LLC | 1,401,783 | $36,629 | 11.32% |
Hardman Johnston Global Advisors LLC | 5,561,806 | $145,329,991 | 5.69% |
13D Management LLC | 383,584 | $10,023,050 | 5.27% |
Prosight Management, LP | 341,521 | $8,923,944 | 4.87% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 593,000 | $15,483,230 | 4.78% |
Tamarack Advisers, LP | 275,000 | $7,185,750 | 3.70% |
Ally Bridge Group (NY) LLC | 142,002 | $3,710,512 | 3.61% |
HealthCor Management, L.P. | 110,000 | $2,874,300 | 2.63% |
Price Jennifer C. | 360,600 | $9,422,478 | 2.25% |